Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the safety and efficacy of Ruxolitinib Cream in pediatric patients with vitiligo. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: NonSegmental Vitiligo | Phase 3 | Status: RECRUITING